Literature DB >> 500813

Polycythemia vera. Increased expression of normal committed granulocytic stem cells in vitro after exposure of marrow to tritiated thymidine.

J W Singer, P J Fialkow, J W Adamson, L Steinmann, C Ernst, S Murphy, K J Kopecky.   

Abstract

In previous studies of two patients with polycythemia vera (PV) and heterozygous at the X-linked locus for glucose-6-phosphate dehydrogenase (G-6-PD), only type A isoenzyme was found in non-lymphoid hematopoietic cells. However, some granulocytic and erythrocytic colonies grown in vitro had type B G-6-PD and therefore arose from presumably normal progenitors. In this study we exposed marrow cells from these same two patients to high-specific activity tritiated thymidine (3HTdR) before culture to kill cells actively synthesizing DNA. Individual granulocytic colonies were plucked and tested for G-6-PD after 14 d of culture. The frequency of type B colonies rose after exposure to 3HTdR from 8/101 to 11/36 in patient 1 and from 0/32 to 6/31 in patient 2 (P less than 0.003). No increase in the frequency of normal erythroid bursts after 3HTdR exposure was seen, implying that in PV, early granulopoiesis, and erythropoiesis are regulated differently. The results demonstrated that only type A granulocytic colonies, arising from the abnormal clone, were removed by the 3HTdR. In addition, for patient 2, statistical analysis indicated there was an absolute increase in normal granulocytic colonies detected in culture. Thus, PV clonal colony-forming units in culture (CFU-C) cycle more rapidly than do normal CFU-C and may suppress proliferation of normal CFU-C in vitro.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 500813      PMCID: PMC371279          DOI: 10.1172/JCI109588

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  12 in total

1.  Gd(--) Abrami: a deficient G-6PD variant with hemizygous expression in blood cells of a woman with primary myelofibrosis.

Authors:  A Kahn; J F Bernard; D Cottreau; J Marie; P Boivin
Journal:  Humangenetik       Date:  1975-10-20

2.  Letter: Bone-marrow responses in polycythemia vera.

Authors:  J F Prchal; A A Axelrad
Journal:  N Engl J Med       Date:  1974-06-13       Impact factor: 91.245

3.  Chronic myelocytic leukemia (CML): failure to detect residual normal committed stem cells in vitro.

Authors:  J W Singer; P J Fialkow; L Steinmann; V Najfeld; S J Stein; W A Robinson
Journal:  Blood       Date:  1979-02       Impact factor: 22.113

4.  Steroids and hematopoiesis. III. The response of granulocytic and erythroid colony-forming cells to steroids of different classes.

Authors:  J W Singer; J W Adamson
Journal:  Blood       Date:  1976-12       Impact factor: 22.113

5.  Polycythemia vera: stem-cell and probable clonal origin of the disease.

Authors:  J W Adamson; P J Fialkow; S Murphy; J F Prchal; L Steinmann
Journal:  N Engl J Med       Date:  1976-10-21       Impact factor: 91.245

6.  Agnogenic myeloid metaplasia: a clonal proliferation of hematopoietic stem cells with secondary myelofibrosis.

Authors:  R J Jacobson; A Salo; P J Fialkow
Journal:  Blood       Date:  1978-02       Impact factor: 22.113

7.  Polycythemia vera. The in vitro response of normal and abnormal stem cell lines to erythropoietin.

Authors:  J F Prchal; J W Adamson; S Murphy; L Steinmann; P J Fialkow
Journal:  J Clin Invest       Date:  1978-04       Impact factor: 14.808

8.  Probable clonal origin of acute myeloblastic leukemia following radiation and chemotherapy of colon cancer.

Authors:  R G Wiggans; R J Jacobson; P J Fialkow; P V Woolley; J S Macdonald; P S Schein
Journal:  Blood       Date:  1978-10       Impact factor: 22.113

9.  Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage.

Authors:  P J Fialkow; R J Jacobson; T Papayannopoulou
Journal:  Am J Med       Date:  1977-07       Impact factor: 4.965

10.  Erythroid colony formation by polycythemia vera bone marrow in vitro. Dependence on erythropoietin.

Authors:  E D Zanjani; J D Lutton; R Hoffman; L R Wasserman
Journal:  J Clin Invest       Date:  1977-05       Impact factor: 14.808

View more
  5 in total

1.  Unregulated proliferation of primitive neoplastic progenitor cells in long-term polycythemia vera marrow cultures.

Authors:  J D Cashman; C J Eaves; A C Eaves
Journal:  J Clin Invest       Date:  1988-01       Impact factor: 14.808

2.  Polycythemia vera. II. Transgression towards leukemia with special emphasis on histological differential diagnosis, cytogenetics and survival.

Authors:  K F Vykoupil; J Thiele; W Stangel; E Krmpotic; A Georgii
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1980

3.  In vitro studies of human pluripotential hematopoietic progenitors in polycythemia vera. Direct evidence of stem cell involvement.

Authors:  R C Ash; R A Detrick; E D Zanjani
Journal:  J Clin Invest       Date:  1982-05       Impact factor: 14.808

4.  Chronic myelogenous leukemia: in vitro studies of hematopoietic regulation in a patient undergoing intensive chemotherapy.

Authors:  J W Singer; J W Adamson; Z A Arlin; S J Kempin; B D Clarkson; P J Fialkow
Journal:  J Clin Invest       Date:  1981-06       Impact factor: 14.808

5.  Polycythemia vera. Physical separation of normal and neoplastic committed granulocyte-macrophage progenitors.

Authors:  J W Singer; J W Adamson; C Ernst; N Lin; L Steinmann; S Murphy; P J Fialkow
Journal:  J Clin Invest       Date:  1980-10       Impact factor: 14.808

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.